Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models

Allen, 2012, Novel late-onset Alzheimer disease loci variants associate with brain gene expression, Neurology, 79, 221, 10.1212/WNL.0b013e3182605801 Antunez, 2011, The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease, Genome Med., 3, 33, 10.1186/gm249 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B Stat. Methodol., 57, 289 Bertram, 2007, Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database, Nat. Genet., 39, 17, 10.1038/ng1934 Braak, 2006, Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry, Acta Neuropathol., 112, 389, 10.1007/s00401-006-0127-z Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809 Chan, 2008, ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro, J. Neurochem., 106, 793, 10.1111/j.1471-4159.2008.05433.x Chapuis, 2013, Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology, Mol. Psychiatry, 18, 1225, 10.1038/mp.2013.1 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Deng, 2012, The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease, Hum. Genet., 131, 1245, 10.1007/s00439-012-1154-6 Desikan, 2014, The role of clusterin in amyloid-beta-associated neurodegeneration, JAMA Neurol., 71, 180, 10.1001/jamaneurol.2013.4560 Eng, 1994, GFAP and astrogliosis, Brain Pathol., 4, 229, 10.1111/j.1750-3639.1994.tb00838.x Ertekin-Taner, 2007, Genetics of Alzheimer's disease: a centennial review, Neurol. Clin., 25, 611, 10.1016/j.ncl.2007.03.009 Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol., 5, R80, 10.1186/gb-2004-5-10-r80 Guerreiro, 2013, TREM2 variants in Alzheimer's disease, N. Engl. J. Med, 368, 117, 10.1056/NEJMoa1211851 Harold, 2009, Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, Nat. Genet., 41, 1088, 10.1038/ng.440 Hernandez, 2010, GSK3: a possible link between beta amyloid peptide and tau protein, Exp. Neurol, 223, 322, 10.1016/j.expneurol.2009.09.011 Hokama, 2014, Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study, Cereb. Cortex, 24, 2476, 10.1093/cercor/bht101 Hollingworth, 2011, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease, Nat. Genet., 43, 429, 10.1038/ng.803 Hu, 2014, Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients, J. Alzheimers Dis., 38, 497, 10.3233/JAD-130854 Ishibashi, 2001, Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and beta subunit of the high-affinity IgE receptor, Gene, 264, 87, 10.1016/S0378-1119(00)00598-9 Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer's disease, N. Engl. J. Med., 368, 107, 10.1056/NEJMoa1211103 Kamalainen, 2013, GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients, J. Alzheimers Dis., 33, 23, 10.3233/JAD-2012-120946 Kamboh, 2012, Genome-wide association study of Alzheimer's disease, Transl. Psychiatry, 2, e117, 10.1038/tp.2012.45 Karch, 2012, Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains, PLoS One, 7, e50976, 10.1371/journal.pone.0050976 Kim, 2013, Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease, J. Neurosci., 33, 4387, 10.1523/JNEUROSCI.4165-12.2013 Koivisto, 2013, Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus, Neurosurgery, 72, 1, 10.1227/NEU.0b013e31827414b3 Laitera, 2014, Increased gamma-secretase activity in idiopathic normal pressure hydrocephalus patients with beta-amyloid pathology, PLoS One, 9, e93717, 10.1371/journal.pone.0093717 Lambert, 2011, Genetics of Alzheimer's disease: new evidences for an old hypothesis?, Curr. Opin. Genet. Dev., 21, 295, 10.1016/j.gde.2011.02.002 Lambert, 2013, Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease, Mol. Psychiatry, 18, 461, 10.1038/mp.2012.14 Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat. Genet., 41, 1094, 10.1038/ng.439 Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nat. Genet., 45, 1452, 10.1038/ng.2802 Leinonen, 2012, Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature, Neuropathol. Appl. Neurobiol., 38, 72, 10.1111/j.1365-2990.2011.01195.x Leinonen, 2010, Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease, Ann. Neurol., 68, 446, 10.1002/ana.22100 Lidstrom, 1998, Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease, Exp. Neurol., 154, 511, 10.1006/exnr.1998.6892 Lu, 1999, The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein, Nature, 399, 784, 10.1038/21650 Malik, 2013, CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing, J. Neurosci., 33, 13320, 10.1523/JNEUROSCI.1224-13.2013 May, 1990, Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat, Neuron, 5, 831, 10.1016/0896-6273(90)90342-D McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Medway, 2014, Review: the genetics of Alzheimer's disease; putting flesh on the bones, Neuropathol. Appl. Neurobiol., 40, 97, 10.1111/nan.12101 Merezhko, 2014, Multiplex assay for live-cell monitoring of cellular fates of amyloid-beta precursor protein (APP), PLoS One, 9, e98619, 10.1371/journal.pone.0098619 Michnick, 2007, Universal strategies in research and drug discovery based on protein-fragment complementation assays, Nat. Rev. Drug Discov., 6, 569, 10.1038/nrd2311 Naj, 2011, Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease, Nat. Genet., 43, 436, 10.1038/ng.801 Natunen, 2013, Effects of NR1H3 genetic variation on the expression of liver X receptor alpha and the progression of Alzheimer's disease, PLoS One, 8, e80700, 10.1371/journal.pone.0080700 Natunen, 2013, Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease, J. Alzheimers Dis., 37, 217, 10.3233/JAD-130104 Neumann, 2007, Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis, J. Neuroimmunol., 184, 92, 10.1016/j.jneuroim.2006.11.032 Nica, 2013, Expression quantitative trait loci: present and future, Philos. Trans. R. Soc. Lond. B. Biol. Sci., 368, 20120362, 10.1098/rstb.2012.0362 Nilselid, 2006, Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms, Neurochem. Int., 48, 718, 10.1016/j.neuint.2005.12.005 Nuutinen, 2009, Clusterin: a forgotten player in Alzheimer's disease, Brain Res. Rev., 61, 89, 10.1016/j.brainresrev.2009.05.007 Nykanen, 2012, Gamma-aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation, J. Biol. Chem., 287, 6743, 10.1074/jbc.M111.309385 Proitsi, 2014, Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood, Neurobiol. Aging, 35, 279, 10.1016/j.neurobiolaging.2013.08.002 Pyykko, 2012, APOE4 predicts amyloid-beta in cortical brain biopsy but not idiopathic normal pressure hydrocephalus, J. Neurol. Neurosurg. Psychiatry, 83, 1119, 10.1136/jnnp-2011-303849 2009 Remy, 2006, A highly sensitive protein-protein interaction assay based on Gaussia luciferase, Nat. Methods, 3, 977, 10.1038/nmeth979 Rinne, 2014, Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus, Neurodegener. Dis., 13, 237, 10.1159/000355256 Rivera, 2005, Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine, J. Alzheimers Dis., 8, 247, 10.3233/JAD-2005-8304 Sannerud, 2011, ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1, Proc. Natl. Acad. Sci. U. S. A., 108, E559, 10.1073/pnas.1100745108 Seppala, 2012, CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings, Neurology, 78, 1568, 10.1212/WNL.0b013e3182563bd0 Simpson, 2010, Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain, Neurobiol. Aging, 31, 578, 10.1016/j.neurobiolaging.2008.05.015 Smyth, 2005, Limma: linear models for microarray data, 397 Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 90, 1977, 10.1073/pnas.90.5.1977 Szymanski, 2011, Alzheimer's risk variants in the clusterin gene are associated with alternative splicing, Transl. Psychiatry, 1, e18, 10.1038/tp.2011.17 Takahashi, 2007, TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis, PLoS Med., 4, e124, 10.1371/journal.pmed.0040124 Terry, 1983, Senile dementia of the Alzheimer type, Ann. Neurol., 14, 497, 10.1002/ana.410140502 Thambisetty, 2012, Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment, Neuroimage, 59, 212, 10.1016/j.neuroimage.2011.07.056 Trabzuni, 2012, MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies, Hum. Mol. Genet., 21, 4094, 10.1093/hmg/dds238 Twine, 2011, Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease, PLoS One, 6, e16266, 10.1371/journal.pone.0016266 Westfall, 1993 Wigge, 1998, The amphiphysin family of proteins and their role in endocytosis at the synapse, Trends Neurosci., 21, 339, 10.1016/S0166-2236(98)01264-8